Medical cannabis changes could expand research, create demand for specialized healthcare training
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →
SARASOTA, Fla. (WWSB) - As federal policies surrounding medical cannabis continue to evolve, healthcare professionals are taking a closer look at what those changes could mean for patients, medical research and the future of medicine.Professor Sabrina Fayez, director of Lake Erie College of Osteopathic Medicine’s (LECOM) Master of Science in Medical Cannabinoid Therapeutics program, joined ABC7 to discuss the changing medical cannabis landscape and the growing need for specialized education.Fayez said the federal government’s move to reclassify medical cannabis as a Schedule III substance represents an important shift in how its potential medical uses are recognized.However, she emphasized that the change does not immediately affect patients enrolled in Florida’s medical marijuana program.“Currently, there are no immediate changes for medical patients in the state of Florida because even though it’s federally recognized as a Schedule 3 medical substance, the state still manages all sta